Oruka Therapeutics, Inc. (ORKA) stock
ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$95.74−0.58 (-0.60%)
Close on Nov 18, 2026Market cap $6.34BP/E –Yield –
Oruka Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oruka Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$100.92M. For fiscal 2025 it was -$88.21M. The highest annual figure on record is -$4.08M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$88.21M | – |
| FY2023 | Dec 31, 2023 | -$5.01M | – |
| FY2022 | Dec 31, 2022 | -$10.91M | – |
| FY2021 | Dec 31, 2021 | -$18.76M | – |
| FY2020 | Dec 31, 2020 | -$7.73M | – |
| FY2019 | Dec 31, 2019 | -$4.80M | – |
| FY2018 | Dec 31, 2018 | -$8.24M | – |
| FY2017 | Dec 31, 2017 | -$17.47M | – |
| FY2016 | Dec 31, 2016 | -$14.99M | – |
| FY2015 | Dec 31, 2015 | -$10.53M | – |
| FY2014 | Dec 31, 2014 | -$9.41M | – |
| FY2013 | Dec 31, 2013 | -$5.29M | – |
| FY2012 | Dec 31, 2012 | -$4.08M | – |
| FY2011 | Dec 31, 2011 | -$6.96M | – |
| FY2010 | Dec 31, 2010 | -$8.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$33.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.59M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$20.87M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$694.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.50M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.62M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.30M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.87M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.23M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.00M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.16M | – |
| Q3 FY2019 | Sep 30, 2019 | -$887.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.19M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.57M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.34M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.25M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.96M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.34M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.84M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.74M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.53M | – |
See a number that looks wrong?